CXCL8 and neoplasm: Mature DC numbers or functions were improved leading to better immune control of the tumour in several mouse models: IL-6 KO mice (95); tumours treated with anti-VEGF antibody (96, 97); and treatment with anti-IL-8 monoclonal antibody (98, 99).